Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
MillionDollar Salaries BillionDollar Stakes The Battle for Top AI Talent Intensifies AutoZone Stock Plunges in FourYear Worst Session Despite Earnings Beat Are Investors Too Optimistic Heading Into June Market Risks May Be Lurking Space Stocks Rally as SpaceX Prospectus Emerges Amid Starship Setback Citi Taps Broadcom as Top Semiconductor Pick for 2026 Citing AI and Networking Potential Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution Cullinan Therapeutics Inc CGEM Q1 2026 Earnings Beat on EPS with NarrowerThanExpected Loss ENPH Q1 2026 Earnings EPS Surprises to the Upside as Enphase Navigates Market Headwinds Target Hospitality Corp TH Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges RenovoRx Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline Procter Gamble PG Edges Higher Amid Defensive Appeal Holds Near MidRange SolarEdge Surges 148 Whats Driving the Solar Stocks Rally Invesco Advantage Municipal Income Trust II VKI Posts Modest Gain Navigating Yield Opportunities and Key Technical Levels Opendoor Technologies Warrants OPENL Slide 7 as Selling Pressure Intensifies Mets New Acquisition Bo Bichette Faces Adjustment Challenges Team Performance Implications Under Scrutiny BP Shares Slide After Board Votes to Remove Chairman Albert Manifold Over Serious Conduct Concerns Amazon UK Boss Says Education System Fails to Prepare Youth for Work DraftKings Posts Strong Q1 2026 Revenue Growth of 17 to 165 Billion Titan International TWI Slides 12 to 726 as Support Level Nears Trevi Therapeutics TRVI Holds Near Resistance After Modest Gain Brighthouse Financial Preferred BHFAN Edges Higher Amid Steady Demand for Income Securities Oaktree Acquisition Corp III Life Sciences OACC Holds Steady Near 1070 as SPAC Investors Await Transaction Announcement Enanta Pharmaceuticals ENTA Edges Higher Testing Resistance Near 1465 Neumora Therapeutics NMRA Holds Steady at 185 as Stock Navigates Tight Range